Meeting
2016 ASCO Annual Meeting
Genome wide association study for anthracycline-induced congestive heart failure.
Authors
Laura Gardner
Indiana University School of Medicine, Indianapolis, IN
Laura Gardner , Fei Shen , Milan Radovich , Lang Li , Kathy Miller , Guanglong Jiang , Dongbing Lai , Anne M. O'Neill , Joseph A. Sparano , Nancy E. Davidson , David A. Cameron , Irmina Gradus-Pizlo , Ronald Mastouri , Thomas M. Suter , Tatiana Foroud , George W. Sledge , Bryan P. Schneider
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Triple-Negative Breast Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 1017)
DOI
10.1200/JCO.2016.34.15_suppl.1017
Abstract #
1017
Poster Bd #
122
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
SNP-SNP interactions and a 4-locus model for prediction the risk of anthracycline-mediated cardiotoxicity in patients with breast cancer.
First Author: Dmitry Yu. Gvaldin
Poster
2020 ASCO Virtual Scientific Program
Genome Wide Association Study (GWAS) of cognitive impairment after blood or marrow transplantation (BMT) for hematologic malignancy.
First Author: Noha Sharafeldin
Poster
2018 ASCO Annual Meeting
Genome-wide association with survival in stage II-III colon cancer clinical trials (NCCTG N0147, Alliance for Clinical Trials in Oncology; NSABP C-08, NRG Oncology).
First Author: Kathryn Penney
Poster
2017 ASCO Annual Meeting
Genomic risk prediction of aromatase inhibitor-related arthralgias (AIA) in breast cancer (BC) patients using a novel analytical algorithm (NAA).
First Author: Raquel E. Reinbolt